Does INCLISIRAN Cause Injection site erythema? 133 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Injection site erythema have been filed in association with INCLISIRAN (LEQVIO). This represents 2.1% of all adverse event reports for INCLISIRAN.
133
Reports of Injection site erythema with INCLISIRAN
2.1%
of all INCLISIRAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Injection site erythema From INCLISIRAN?
Of the 133 reports, 6 (4.5%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INCLISIRAN. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does INCLISIRAN Cause?
Arthralgia (689)
Myalgia (518)
Injection site pain (488)
Low density lipoprotein increased (423)
Pain in extremity (417)
Pain (342)
Fatigue (325)
Drug ineffective (318)
Diarrhoea (309)
Dyspnoea (297)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which INCLISIRAN Alternatives Have Lower Injection site erythema Risk?
INCLISIRAN vs INCOBOTULINUMTOXINA
INCLISIRAN vs INDACATEROL
INCLISIRAN vs INDAPAMIDE
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL
INCLISIRAN vs INDAPAMIDE\PERINDOPRIL ARGININE